Market Research Trends

The point-of-care molecular diagnostics market is expected to be worth US$ 4.4 billion in 2023, rising to US$ 11.1 billion by 2033. During the forecast period, the market is expected to grow at a CAGR of 9.7%. Many current point-of-care diagnostics are based on lateral flow immunoassay technology, and these instruments use antibodies to detect the presence of an analyte, such as cancer biomarkers, in a short period of time, thereby accelerating the growth of the point-of-care molecular diagnostics market. According to the point-of-care molecular diagnostics market report, the growing trend toward preventive medicine is driving up demand for point-of-care molecular diagnostics. This is expected to significantly influence future trends in point-of-care molecular diagnostics. According to UN data, the number of older adults has been steadily increasing for decades. As a result of this demographic shift, the prevalence of various chronic diseases is increasing, making point-of-care ...

According to Future Market Insights' (FMI) point-of-care molecular diagnostics market survey, the market is expected to grow at an average rate of 8% from 2022 to 2032. Many current point-of-care diagnostics are based on lateral flow immunoassay technology, and these instruments use antibodies to detect the presence of an analyte, such as cancer biomarkers, in a short period of time, thereby accelerating the growth of the point-of-care molecular diagnostics market. According to the point-of-care molecular diagnostics market report, the growing trend toward preventive medicine is driving up demand for point-of-care molecular diagnostics. This is expected to significantly influence future trends in point-of-care molecular diagnostics. According to UN data, the number of older adults has been steadily increasing for decades. As a result of this demographic shift, the prevalence of various chronic diseases is increasing, making point-of-care molecular diagnostics devices more ap...

Per the  point-of-care molecular diagnostics market survey  by Future Market Insights (FMI), the market is forecasted to move forward at an average pace and register a CAGR of 8% from 2022 to 2032. Many current  POC diagnostics  are based on lateral flow immunoassay technology, and these instruments use antibodies to detect the presence of an analyte, such as cancer biomarkers, in a short period and thus, having the effect of spurring the  point-of-care molecular diagnostics market growth  to a large extent. As per the  point-of-care molecular diagnostics market report , the  demand for point-of-care molecular diagnostics  is on a surge owing to the growing trend toward preventive medicine. This is considered to shape the  point-of-care molecular diagnostics future trends  to a large extent. According to United Nations data, the number of older adults has steadily increased for decades. As a result of this demographic shi...